dc.contributor.author |
Sharkey, Jack |
|
dc.contributor.author |
Starkey Lewis, Philip J. |
|
dc.contributor.author |
Barrow, Michael |
|
dc.contributor.author |
Alwahsh, Salamah M |
|
dc.contributor.author |
Forbes, Shareen |
|
dc.contributor.author |
Forbes, Stuart J. |
|
dc.contributor.author |
Park, B Kevin |
|
dc.date.accessioned |
2021-05-04T08:00:05Z |
|
dc.date.accessioned |
2022-05-22T08:54:12Z |
|
dc.date.available |
2021-05-04T08:00:05Z |
|
dc.date.available |
2022-05-22T08:54:12Z |
|
dc.date.issued |
2017-04 |
|
dc.identifier.uri |
https://pubmed.ncbi.nlm.nih.gov/28214127/ |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/8234 |
|
dc.description.abstract |
Background aims: Tracking cells during regenerative cytotherapy is crucial for monitoring their safety and efficacy. Macrophages are an emerging cell-based regenerative therapy for liver disease and can be readily labeled for medical imaging. A reliable, clinically applicable cell-tracking agent would be a powerful tool to study cell biodistribution.
Methods: Using a recently described chemical design, we set out to functionalize, optimize and characterize a new set of superparamagnetic iron oxide nanoparticles (SPIONs) to efficiently label macrophages for magnetic resonance imaging-based cell tracking in vivo.
Results: A series of cell health and iron uptake assays determined that positively charged SPIONs (+16.8 mV) could safely label macrophages more efficiently than the formerly approved ferumoxide (-6.7 mV; Endorem) and at least 10 times more efficiently than the clinically approved SPION ferumoxytol (-24.2 mV; Rienso). An optimal labeling time of 4 h at 25 µg/mL was demonstrated to label macrophages of mouse and human origin without any adverse effects on cell viability whilst providing substantial iron uptake (>5 pg Fe/cell) that was retained for 7 days in vitro. SPION labeling caused no significant reduction in phagocytic activity and a shift toward a reversible M1-like phenotype in bone marrow-derived macrophages (BMDMs). Finally, we show that SPION-labeled BMDMs delivered via the hepatic portal vein to mice are localized in the hepatic parenchyma resulting in a 50% drop in T2* in the liver. Engraftment of exogenous cells was confirmed via immunohistochemistry up to 3 weeks posttransplantation. |
en_US |
dc.description.sponsorship |
UK Regenerative Medicine Platform Safety and Efficacy Hub (grant ref MR/K026739/1) |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.subject |
MRI; cell therapy; cell tracking; liver fibrosis; macrophage. |
en_US |
dc.title |
Functionalized superparamagnetic iron oxide nanoparticles provide highly efficient iron-labeling in macrophages for magnetic resonance– based detection in vivo |
en_US |
dc.type |
Article |
en_US |